Neurofibromatoses are genetic disorders of the nervous system that affect the growth and development of nerve cell tissue. The disorders, known as neurofibromatosis type 1 (NF1) and neurofibromatosis type 2 (NF2), are currently treated through symptom control. During this free online chat, Dr. Rothner will answer your questions about the two types of disorders and their causes, symptoms, and treatment.

Dr. A. David Rothner is Chairman Emeritus, Section of Child Neurology; Director, Pediatric/Adolescent Headache Program; and Director, Cleveland Clinic Center for Consumer Health Information.

Dr. Rothner received his medical degree from the University of Illinois College of Medicine. Following completion of an internship and junior residency in pediatrics at the Presbyterian-St. Luke’s Hospital in Chicago, he completed a senior residency in pediatrics at Columbia Presbyterian Medical Center’s Babies Hospital in New York City. Dr. Rothner continued his training at the Neurologic Institute of the Columbia Presbyterian Medical Center with a fellowship in pediatric neurology. He has been a member of the faculty of Pediatrics and Neurology in Cleveland Clinic since 1973.

Currently, Dr. Rothner is the Chairman Emeritus of the Section of Child Neurology at Cleveland Clinic. He serves as a Fellow of the American Academies of Pediatrics and Neurology, and has served on the advisory boards of the Epilepsy Foundation of America and the March of Dimes. Dr. Rothner directs the Pediatric/Adolescent Headache Program and directs the efforts of the Cleveland Clinic Center for Consumer Health Information in the Education Institute.

Dr. Rothner sits on the editorial boards of Pediatrics Today and Headache Quarterly. He has published over 250 original articles, book chapters, tapes, and reviews in the areas of epilepsy, headaches in children, and general pediatric neurology. He is the co-editor of the textbook, Headache in Children and Adolescents.

Go to check other upcoming chat page.